KALA BIO Statistics

Total Valuation

KALA BIO has a market cap or net worth of $46.85 million. The enterprise value is $38.08 million.

Market Cap	46.85M
Enterprise Value	38.08M

Important Dates

The next estimated earnings date is Friday, August 7, 2026, before market open.

Earnings Date	Aug 7, 2026
Ex-Dividend Date	n/a

Share Statistics

KALA BIO has 18.59 million shares outstanding. The number of shares has increased by 3,212.14% in one year.

Current Share Class	18.59M
Shares Outstanding	18.59M
Shares Change (YoY)	+3,212.14%
Shares Change (QoQ)	+4,580.47%
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	0.65%
Float	18.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.35
P/TBV Ratio	4.35
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.91

Current Ratio	7.91
Quick Ratio	5.68
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-15.36

Financial Efficiency

Return on equity (ROE) is -238.68% and return on invested capital (ROIC) is -85.94%.

Return on Equity (ROE)	-238.68%
Return on Assets (ROA)	-69.26%
Return on Invested Capital (ROIC)	-85.94%
Return on Capital Employed (ROCE)	-311.89%
Weighted Average Cost of Capital (WACC)	-9.00%
Revenue Per Employee	n/a
Profits Per Employee	-$3.28M
Employee Count	6
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -98.93% in the last 52 weeks. The beta is -2.41, so KALA BIO's price volatility has been lower than the market average.

Beta (5Y)	-2.41
52-Week Price Change	-98.93%
50-Day Moving Average	4.06
200-Day Moving Average	81.89
Relative Strength Index (RSI)	39.88
Average Volume (20 Days)	147,900

Short Selling Information

The latest short interest is 70,709, so 0.38% of the outstanding shares have been sold short.

Short Interest	70,709
Short Previous Month	42,592
Short % of Shares Out	0.38%
Short % of Float	0.38%
Short Ratio (days to cover)	0.88

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-33.56M
Pretax Income	-19.65M
Net Income	-19.65M
EBITDA	-33.23M
EBIT	-33.56M
Earnings Per Share (EPS)	-$6.34

Full Income Statement

Balance Sheet

The company has $8.76 million in cash and n/a in debt, giving a net cash position of $8.76 million or $0.47 per share.

Cash & Cash Equivalents	8.76M
Total Debt	n/a
Net Cash	8.76M
Net Cash Per Share	$0.47
Equity (Book Value)	10.76M
Book Value Per Share	0.58
Working Capital	10.76M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$26.06 million and capital expenditures -$15,000, giving a free cash flow of -$26.08 million.

Operating Cash Flow	-26.06M
Capital Expenditures	-15,000
Depreciation & Amortization	328,250
Net Borrowing	-22.48M
Free Cash Flow	-26.08M
FCF Per Share	-$1.40

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KALA BIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3,212.14%
Shareholder Yield	-3,212.14%
Earnings Yield	-41.95%
FCF Yield	-55.66%

Analyst Forecast

The average price target for KALA BIO is $75.00, which is 2,876.19% higher than the current price. The consensus rating is "Hold".

Price Target	$75.00
Price Target Difference	2,876.19%
Analyst Consensus	Hold
Analyst Count	1
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Splits

The last stock split was on May 11, 2026. It was a reverse split with a ratio of 1:50.

Last Split Date	May 11, 2026
Split Type	Reverse
Split Ratio	1:50

Scores

Altman Z-Score	n/a
Piotroski F-Score	1